Nath Bio-Genes (I) Current Assets
The Current Assets of Nath Bio-Genes (I) (NATHBIOGEN.NS) as of Oct 29, 2026 is 6.93 B INR. In the previous year, Current Assets was 7.00 B INR — a change of -0.91% (lower).
Get this data via API
Financial Data API
Current Assets
6.93 BINR
YoY
-0.91%
Last updated:
The Nath Bio-Genes (I) Current Assets history
3 Years
10 Years
25 Years
Max
| YEAR | Current Assets | YoY |
|---|---|---|
| 6.93 BINR | -0.91% | |
| 7.00 BINR | +20.77% | |
| 5.79 BINR | +4.27% | |
| 5.56 BINR | +38.08% | |
| 4.02 BINR | +9.13% | |
| 3.69 BINR | -24.39% | |
| 4.88 BINR | +63.46% | |
| 2.98 BINR | -15.39% | |
| 3.53 BINR | +45.78% | |
| 2.42 BINR | -5.98% | |
| 2.57 BINR | +14.61% | |
| 2.25 BINR | +21.13% | |
| 1.85 BINR | +54.79% | |
| 1.20 BINR | +24.45% | |
| 962.23 MINR | — |
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Nath Bio-Genes (I) Stock analysis
Frequently Asked Questions about Nath Bio-Genes (I) stock
Current Assets of Nath Bio-Genes (I) is 6.93 B INR in 2026.
Current Assets of Nath Bio-Genes (I) changed from 7.00 B INR to 6.93 B INR, representing a -0.91% change. The value is lower than the previous year.
On Eulerpool you can find the complete historical development of Current Assets Nath Bio-Genes (I) since 2006 – with annual values, charts, and detailed analysis.
Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.
Current Assets's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's Nath Bio-Genes (I) historically and in real time.
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Balance Sheet — Nath Bio-Genes (I)
All Key Metrics — Nath Bio-Genes (I)
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth